Health
COVID: new antibody treatment could offer up to 18 months’ protection against severe disease – The Conversation UK
AstraZeneca’s durable monoclonal antibody treatment has shown promise in phase 3 clinical trials.
A new treatment could soon help protect people from developing severe COVID. AstraZeneca has just released results from a phase 3 clinical trial the final stage of testing before a drug is authorised that suggest its new COVID treatment, AZD7442, is effective…
Continue Reading
-
Noosa News21 hours agoBrisbane’s original 1979 electric trains take one last journey
-
General20 hours agoParis opens River Seine for public swimming for first time since 1923
-
General4 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News13 hours agoRainbow Beach surfer’s untold 7/7 story